Results

eNauka >  Rezultati >  Long-term overall survival and progression-free survival in idiopathic pulmonary fibrosis treated by pirfenidone or nintedanib or their switch. Real world data from the EMPIRE registry
Naziv: Long-term overall survival and progression-free survival in idiopathic pulmonary fibrosis treated by pirfenidone or nintedanib or their switch. Real world data from the EMPIRE registry
Autori: Vasakova, Martina; Sterclova, Martina; Mogulkoc, Nesrin; Lawandowska, Katerzyna; Mueller, Veronika; Hajkova, Marta; Jovanovic, Dragana D; Tekavec-Trkanjec, Jasna; Kramer, Mordechai; Studnicka, Michael;
Stoeva, Natalia; Littnerova, Simona; Hejduk, Karel; Dusek, Ladislav;
Godina: 2019
Publikacija: EUROPEAN RESPIRATORY JOURNAL
ISSN: 0903-1936 European Respiratory Journal Pretraži identifikator
Tip rezultata: Konferencijski rad
Kolacija: vol. 54
DOI: 10.1183/13993003.congress-2019.PA4720
WoS-ID: 000507372406214
URI: https://enauka.gov.rs/handle/123456789/804623
Projekat: Boehringer Ingelheim
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
Mp kategorija će biti prikazana naknadno.

2
OpenCitations
4
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.